UK gene therapeutics firm files US IPO

By Sam Kerr
20 Jul 2020

Freeline Theraputics, the UK gene therapeutics company, has filed to list in the US on the Nasdaq exchange, continuing the trend of biotech companies seeking to raise capital in the equity capital markets.

Freeline has not yet revealed the size or timeline of its deal, but it is part of what has become an important theme in US and European ECM in 2020.

JP Morgan, Morgan Stanley, Evercore and Wedbush PacGrow are working on the deal.

According to Dealogic, biotech ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial